Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 154   

Articles published

MRK 60.49 -0.15 (-0.25%)
price chart
Earnings Buzz: Pfizer Inc (PFE), Merck & Co Inc (MRK), Bristol-Myers Squibb Co ...
Pfizer Inc. (NYSE:PFE) shares edged up 0.5 percent Tuesday, despite cutting its full-year 2015 earnings forecast due to a stronger U.S.
Whisper Numbers: Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), And Bristol ...  Bidness ETC
Pfizer, Merck and Bristol-Myers Squibb Report Solid Results  Wall Street Journal
PeptiDream Announces Peptide Discovery Collaboration Agreement with Merck ...
Under the agreement, PeptiDream will use its proprietary Peptide Discovery Platform System (PDPS) technology to generate macrocylic/constrained peptides against multiple targets of interest selected by Merck & Co. Inc. Merck & Co. Inc. will have the ...
Merck & Co. Inc. (MRK) Closes 1.3% Up on the Day for May 04
Merck & Co. Inc. currently has a total float of 2.83 billion shares and moves 11.71 million a day, on average. The stock opened at $60.14 on May 04 and traded between a low of $60.03 and a high of $60.95.
Bruce Kuhlik just Unloaded 156902 shares of Merck & Co., Inc. (NYSE:MRK ...
Shareholder Bruce Kuhlik of Merck & Co., Inc. (NYSE:MRK) 60.64 +0.78 1.30% , sold some 156,902 of the firm shares worth $9,386,646 U.S Dollars with an average of $59.8 stock price for a share.
Merck & Co., Inc. (MRK) Issues FY15 Earnings Guidance  Dakota Financial News
Merck & Co. Inc. (MRK) Jumped After Q1 Earnings Exceeded Expectations  RTT News
Merck & Co., Inc. Raises 2015 Outlook; Q1 Results Beat Estimates On Growth ...
Before the market opened today, pharmaceutical giant Merck & Co., Inc. (NYSE:MRK) announced first-quarter results for fiscal'15, reporting higher-than-expected growth in earnings and revenues, primarily due to increasing sales of its newer drugs.
Merck & Co., Inc. Seeks FDA Approval As Keytruda Is Shown To Shrink Lung ...
Merck & Co., Inc. (NYSE:MRK) announced that it has submitted an application to the US Food and Drug Administration (FDA) seeking approval for its cancer drug Keytruda, to treat patients with non-small cell lung cancer (NSCLC), after a study comparing ...
Merck & Co. Seek FDA Approval for Melanoma Drug Keytruda  Healthcare Global
Test May Show Merck Melanoma Drug's Success in Lung Cancer  Bloomberg
Merck & Co., Inc. (MRK) Q1 Earnings Preview: What To Expect
Pharmaceutical giant Merck & Co., Inc. (NYSE:MRK), and also the second-largest US drug-maker, is scheduled to announce its financial results for the first quarter of fiscal year 2015 (1QFY15) on Tuesday, April 28 before the market opens.
What to Expect From Merck and Pfizer Earnings  24/7 Wall St.
Merck Earnings: What to Watch  Wall Street Journal (blog)
Why Merck & Co. Inc. (MRK), JetBlue Airways Corporation (JBLU) and Rent-A ...
MerckLogo e1282588089406 Why Merck & Co. Inc. (MRK), JetBlue Airways Corporation Stocks dropped quickly while energy and gold soared, after news that Iran had seized a Western cargo carrier led to speculation of it being a U.S.
Will Merck & Co., Inc.'s (NYSE:MRK) New Drugs Be Able To Beat Competitors ...
It was announced on Friday by Merck & Co. Inc. (NYSE:MRK) that its new combo drug has been successful in treating up to 95% of hepatitis C in patients who have been suffering from HIV and HCV.
If It Gets Approval Quickly, Merck Could Challenge Gilead Sciences In ...  Seeking Alpha
What's Wall Street Been Saying About Gilead Lately?  Benzinga
Merck & Co., Inc. Announces $434 Million Collaboration With Arvinas Over ...
Merck & Co., Inc. (NYSE:MRK) announced Tuesday its decision to join hands with a privately held biotech firm Arvinas LLC for expediting the development of novel therapeutics, taking advantage of Arvinas' proteolysis-targeting chimera (PROTAC ...
Merck & Co. Inc. (NYSE:MRK) Releases A Strategic Alliances In Which ...  StreetWise Report